1. Zhang, Wenqian, Li, Tong, Hu, Bin, Li, Hui. . PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma. In Technology in cancer research & treatment, 19, 1533033820957030. doi:10.1177/1533033820957030. https://pubmed.ncbi.nlm.nih.gov/33084541/
2. Shen, Hui, He, Min, Lin, Ruirong, Mohan, Man, Wang, Jian. 2019. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. In Journal of experimental & clinical cancer research : CR, 38, 247. doi:10.1186/s13046-019-1250-8. https://pubmed.ncbi.nlm.nih.gov/31182136/
3. Cai, Tiantian, Yao, Wendong, Qiu, Lei, Shi, Zheng, Du, Yi. 2022. PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner. In Molecular biology reports, 49, 3693-3704. doi:10.1007/s11033-022-07209-3. https://pubmed.ncbi.nlm.nih.gov/35122599/
4. Mao, Deli, Zhou, Zhijun, Chen, Hengxing, Liu, Mingyang, Zhang, Changhua. 2023. Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer. In Cancer letters, 572, 216351. doi:10.1016/j.canlet.2023.216351. https://pubmed.ncbi.nlm.nih.gov/37591356/
5. Liu, Jianhua, Chen, Hao, Qiao, Guibin, Tian, Jie, Wu, Yi-Long. 2022. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma. In Cancer immunology, immunotherapy : CII, 72, 881-893. doi:10.1007/s00262-022-03288-0. https://pubmed.ncbi.nlm.nih.gov/36121452/
6. Han, Xu, Zhang, Ali, Wang, Pan, Yang, Jing, Ji, Peng. 2024. Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor. In The American journal of pathology, 194, 1986-1996. doi:10.1016/j.ajpath.2024.07.004. https://pubmed.ncbi.nlm.nih.gov/39069167/
7. Zhang, Wenqian, Yu, Lei, Xu, Cong, Pang, Xinya, Ren, Weihao. 2024. PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25. In Cell biology international, 48, 1285-1300. doi:10.1002/cbin.12197. https://pubmed.ncbi.nlm.nih.gov/38894536/